Inorganic arsenite-induced malignant transformation of human prostate epithelial cells

被引:111
作者
Achanzar, WE
Brambila, EM
Diwan, BA
Webber, MM
Waalkes, MP
机构
[1] NIEHS, Inorgan Carcinogenesis Sect, Comparat Carcinogenesis Lab, NCI, Res Triangle Pk, NC 27709 USA
[2] NCI, SAIC Frederick, Intramural Res Support Program, Frederick, MD 21701 USA
[3] Michigan State Univ, Dept Med, E Lansing, MI 48824 USA
[4] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2002年 / 94卷 / 24期
关键词
D O I
10.1093/jnci/94.24.1888
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although several epidemiologic studies show an association between arsenic exposure and prostate cancer, it is still unknown whether human prostate epithelial cells are directly susceptible to arsenic-induced transformation. This study was designed to determine whether the nontumorigenic human prostate epithelial cell line RWPE-1 could be malignantly transformed in vitro by arsenite. RWPE-1 cells were continuously exposed to 5 muM arsenite and monitored for signs of transformation, assessed as changes in matrix metalloproteinase-9 levels. After 29 weeks of exposure, the arsenite-exposed RWPE-1 cells (referred to as CAsE-PE) showed a marked increase in matrix metalloproteinase-9 secretion, a common finding in prostate malignancies. Malignant transformation was confirmed when CAsE-PE cells produced aggressive undifferentiated malignant epithelial tumors in nude mice. The tumors stained positive for human prostate-specific antigen, confirming their origin. These results are the firs; report of arsenite-induced malignant transformation of a human epithelial cell line and provide an important in vitro model for studying the mechanisms underlying arsenic-induced carcinogenesis in humans.
引用
收藏
页码:1888 / 1891
页数:4
相关论文
共 26 条
[11]  
2-A
[12]   MATRIX METALLOPROTEINASE-9 EXPRESSION IN PRIMARY HUMAN PROSTATIC ADENOCARCINOMA AND BENIGN PROSTATIC HYPERPLASIA [J].
HAMDY, FC ;
FADLON, EJ ;
COTTAM, D ;
LAWRY, J ;
THURRELL, W ;
SILCOCKS, PB ;
ANDERSON, JB ;
WILLIAMS, JL ;
REES, RC .
BRITISH JOURNAL OF CANCER, 1994, 69 (01) :177-182
[13]  
IARC (International Agency for Research on Cancer), 1987, IARC Monographs On the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Overall evaluations of Carcinogenicity: An updating of IARC Monographs, V1-42, P100
[14]   Cancer statistics, 2002 [J].
Jemal, A ;
Thomas, A ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (01) :23-47
[15]   Hormones and cancer in humans [J].
Key, TJA .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 333 (1-2) :59-67
[16]   Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites [J].
Kitchin, KT .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 172 (03) :249-261
[17]   Drinking water arsenic in Utah: A cohort mortality study [J].
Lewis, DR ;
Southwick, JW ;
Ouellet-Hellstrom, R ;
Rench, J ;
Calderon, RL .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 (05) :359-365
[18]   Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic [J].
Liu, J ;
Chen, H ;
Miller, DS ;
Saavedra, JE ;
Keefer, LK ;
Johnson, DR ;
Klaassen, CD ;
Waalkes, MP .
MOLECULAR PHARMACOLOGY, 2001, 60 (02) :302-309
[19]   Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China [J].
Liu, T ;
Liu, J ;
LeCluyse, EL ;
Zhou, YS ;
Cheng, ML ;
Waalkes, MP .
TOXICOLOGICAL SCIENCES, 2001, 59 (01) :185-192
[20]  
Prasad Sarada C., 1996, Scanning Microscopy, V10, P1093